Financial Ratios

NECTAR LIFESCIENCES LTD.

NSE : NECLIFEBSE : 532649ISIN CODE : INE023H01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE30.110.06 (+0.2 %)
PREV CLOSE ( ) 30.05
OPEN PRICE ( ) 30.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 43968
TODAY'S LOW / HIGH ( )30.05 30.65
52 WK LOW / HIGH ( )14.36 45.7
NSE30.150.05 (+0.17 %)
PREV CLOSE( ) 30.10
OPEN PRICE ( ) 30.15
BID PRICE (QTY) 30.15 (2801)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 541696
TODAY'S LOW / HIGH( ) 30.05 30.75
52 WK LOW / HIGH ( )14.65 45.7
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-1.001.13-3.261.342.11
   CEPS(Rs)1.633.67-0.574.054.93
   DPS(Rs)0.000.000.000.050.05
   Book NAV/Share(Rs)47.4748.4647.3050.5949.26
   Tax Rate(%)44.8126.2913.5915.9019.16
Margin Ratios
   Core EBITDA Margin(%)3.138.255.768.268.47
   EBIT Margin(%)2.225.881.556.126.64
   Pre Tax Margin(%)-2.331.78-4.801.351.88
   PAT Margin (%)-1.291.32-4.151.141.52
   Cash Profit Margin (%)2.104.27-0.733.443.55
Performance Ratios
   ROA(%)-0.991.06-2.921.131.74
   ROE(%)-2.092.36-6.662.684.38
   ROCE(%)2.065.791.418.2410.28
   Asset Turnover(x)0.770.810.700.991.15
   Sales/Fixed Asset(x)1.121.231.151.762.11
   Working Capital/Sales(x)5.135.5035.127.228.46
Efficiency Ratios
   Fixed Capital/Sales(x)0.890.810.870.570.47
   Receivable days75.9277.8979.8966.2668.75
   Inventory Days139.22118.20161.77130.67103.93
   Payable days109.48107.32137.2899.2484.01
Valuation Parameters
   PER(x)0.0021.300.007.388.10
   PCE(x)9.706.55-32.352.443.47
   Price/Book(x)0.330.500.390.200.35
   Yield(%)0.000.000.000.510.29
   EV/Net Sales(x)0.720.830.840.410.45
   EV/Core EBITDA(x)11.158.1211.474.404.69
   EV/EBIT(x)28.1612.2147.306.066.13
   EV/CE(x)0.500.580.550.370.47
   M Cap / Sales0.230.320.270.090.14
Growth Ratio
   Net Sales Growth(%)-8.678.20-34.75-15.1648.49
   Core EBITDA Growth(%)-42.4650.63-49.20-17.6411.51
   EBIT Growth(%)-65.73313.28-83.05-21.8316.27
   PAT Growth(%)-188.69134.62-343.33-36.49-9.25
   EPS Growth(%)-188.69134.62-343.33-36.49-9.25
Financial Stability Ratios
   Total Debt/Equity(x)0.710.790.850.690.82
   Current Ratio(x)1.381.351.041.291.28
   Quick Ratio(x)0.630.690.550.510.58
   Interest Cover(x)0.491.440.241.281.40
   Total Debt/Mcap(x)2.121.592.173.512.36

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.